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Abstract 
Background: Urinary Liver type fatty acid binding protein (L-FABP) is an early biomarker for renal 
damage. A few studies have been published analyzing the potential use of urinary Liver type fatty acid binding 
protein (L-FABP) as a biomarker for acute kidney injury. However no study has been done related to Acute 
Kidney Injury associated with contrast administration. 
Aim: To search for new markers to identify Acute Kidney Injury (AKI) associated with contrast administration 
earlier than serum creatinine. 
Material and Methods: We studied 100 consecutive patients with normal serum creatinine undergoing 
angiographic procedure. We assessed urinary liver type fatty acid binding protein (L-FABP) levels at basal, 2h 
4h, 12h, 24 h and 48 hours after the angiographic procedure. Serum creatinine was measured at basal, 24h and 48 
hours after the procedure.  
Results: There was a significant rise in urinary L-FABP levels at 12 hours after the angiographic procedure. The 
presence of contrast induced nephropathy associated with acute Kidney Injury was 9%. 
Conclusion: The present study highlighted the importance of urinary L-FABP in detecting Acute Kidney Injury 
associated with contrast administration earlier than Serum creatinine.  
Keywords: Liver type fatty acid binding protein (L-FABP).   Glomerular Filtration Rate (GFR), Contrast 
induced acute kidney injury (CI-AKI). 
 
INTRODUCTION 
Renal Failure is a silent epidemic of the 21st century. Its occurrence is universal; not confined to the developed 
countries. The numbers afflicted with Renal failure are going to rise sharply because of the rising incidence of 
diabetes mellitus and hypertension . Glomerular filtration rate is routinely assessed by measuring the serum 
markers such as urea nitrogen and serum creatinine. Although these markers are widely used to assess renal 
function, they do not perform optimally in certain clinical settings. Radio-contrast administration is one of the 
important reasons for Acute Kidney Injury. Acute Kidney Injury is an independent risk factor for mortality in 
adult and children 
(1-3)
 even with a small increase in serum creatinine 
(4-5).
 Radiological procedures requiring 
intravascular administration of iodinated contrast media are becoming a common source of an iatrogenic disease 
known as contrast induced nephropathy (CIN).
6.
  Acute Kidney Injury is defined as an acute impairment of the 
renal function manifested by an absolute increase in the serum creatinine level of at least 0.5 mg/dl or by a 
relative increase of at least 25% from the baseline level 
7.
 Now a days Cardiologists are being asked more 
frequently to perform angiography in increasing number of patients, in which contrast induced nephropathy (CIN) 
is a potentially serious complication.
8.
  Contrast-induced nephropathy (CIN) is at present the third leading cause 
of hospital-acquired acute kidney injury (AKI).
9
 Increased serum creatinine values typically occur 3-5 days after 
contrast administration and return to baseline levels within 1-3 weeks
8,
 when patients are discharged from the 
hospital. Unfortunately, serum creatinine is an unreliable indicator during acute changes in the kidney function
10.  
A marked reduction in the glomerular filtration rate (GFR) can be present before it is reflected in a rise in serum 
creatinine levels. All these reasons contribute to significant delay in the diagnosis of acute Kidney Injury 
associated with contrast administration. More over the renal function may not return to baseline, leading to an 
increased risk of chronic Kidney Injury.
 4
 Therefore new markers that help to identify Acute Kidney Injury 
earlier than serum creatinine are required for timely treatment. 
Urinary liver-type fatty acid binding protein (L-FABP) is a fatty acid binding protein having a molecular weight 
of approximately 14 kDa, with its distribution confined to the proximal tubular cells of the human kidney
11
.  In 
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healthy human kidney L-FABP is reportedly found in the cytoplasm of the proximal tubular cells and is rapidly 
released into the tubular lumen in response to ischaemia or oxidative stress
. 12-14
 
One report suggests that the increase in L-FABP level reaches a maximum within 24h after contrast medium 
exposure and that L-FABP level could be an indicator of CI-AKI 
15
. However, whether L-FABP level acts an 
indicator of CI-AKI in patients undergoing angiography remains unknown. Hence we conducted this study to 
determine whether urinary L-FABP level acts as an indicator of the CI-AKI and to examine the changes in 
urinary L-FABP levels in patients undergoing angiography. 
Table1: Basal clinical characteristics of patients undergoing angiography. 
Parameter  Value 
Age in years 45.8 ±9.0 
Systolic BP, mmHg 134.5±27.0 
Diastolic BP, mmHg 81.5±19.0 
Heamoglobin, g/dl 13.5±2.0 
HbA1c % 5.0±2.5 
Serum creatinine, mg/dl 1.2±0.18 
eGFR byMDRD equation, ml/min 80.2±21.0 
Cholesterol, mg/dl 165±41 
HDL, mg/dl 45±9 
Fasting Blood Sugar, mg/dl 116±39 
 
MATERIALS AND METHODS 
The study was performed in one hundred consecutive patients undergoing angiographic procedure. The study 
was approved by the Ethics Committee of Micropath Medical Center, Gurgaon, Haryana.  Written informed 
consent was obtained from each patient before enrolment. All consecutive adult patients undergoing coronary 
angiographic procedure from January, 2010 to October, 2013 were included. Clinical characteristics of all 
patients from whom urine was evaluated for L-FABP are reported in Table No.1. Patients with diabetic mellitus 
comprised 36 of 20 male and 16 females. Patients with non-diabetic mellitus comprised 64 of 40 male and 24 
females. Among diabetic patients, 11 were treated with insulin and the rest with oral hypoglycemic drugs. 
 All subjects were discharged home from the angiography area after 8 hours of their procedure with advice to 
give specimen at scheduled time and encouraged to drink about 1.5 liters of water at least for the first 24 hours. 
The coronary angiography was performed by a consultant doctor in a standard manner using femoral artery. We 
excluded patients with pre-existing chronic kidney disease, serum creatinine greater than 1.5 mg/dl in males and 
1.3 mg/dl in females. None of the subjects investigated had received nephrotoxic drugs at least 2 weeks before 
and during the study period.  Before the procedure, all of the participating patients were given their urine and 
blood specimens for investigations such as cholesterol, High Density Lipoprotein, (HDL), Triglycerides, 
Hemoglobin, HbA1C and Fasting Blood Sugar (FBS). Blood pressure (BP) also studied on admission. Each 
patient was given low-osmolar contrast (iodizanol or iopromide) medium. Specific protocols and medications for 
contrast induced nephropathy prevention were not used in this study, but patients were persistently encouraged 
to drink plenty of fluids and oral fluid intake was maximally encouraged.  
Blood samples were collected for serum creatinine and other screening evaluation before (at basal level). 
Thereafter urine samples were collected at 2 hours, 4 hours, 8 hours, 12 hours and 24 hours after the 
angiographic procedure. Urinary Samples were kept for 30 minutes at room temperature then supernatant was 
stored at -80 deg C. Serum creatinine was assessed before ( at basal level), and 24h and 48 hours after the 
procedure using Jaffe method.  L-FABP was evaluated using a commercially available enzyme-linked 
immunosorbent assay from Hycult Biotech, Frontstraat 2a, The Netherlands.  L-FABP test was performed 
according to manufactures instruction. For the choice of optimal cut-off, receiver operating characteristic (ROC) 




The Youden index is defined as follows: 
(sensitivity+specificity)-1. The best cut-off is the highest Youden index. The commercial statistical software 
package SPSS17.0 (SPSS, Inc, Chicago, IL, USA) was utilized. Results are evaluated with 95% confidence 
intervals. The significance level was< 0.05. 
 
RESULTS 
Demographic data, clinical and biochemical criteria of the studied groups are presented in Table 1. The present 
study revealed an increase in Urinary L-FABP, at 2hours, 4hours, 8 hour , 12hours, and 24 hours after coronary 
angiography procedure (Table 2). Urinary L-FABP levels were increased at 4hours, 8 hours, 24 hours and 48 
hours but highest levels were noted at 12 hours  after the procedure. There was a mild increase in serum 
creatinine at 24h and milder at 48 hours after the angiographic procedure, but there was no significant increase in 
eGFR during 48 hours of the procedure (Table 2).  
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Fig.1. Receiver operative characteristics (ROC) showing curve against serum creatinine 48 hours vs 12 hours 
urinary L-FABP and contrast induced acute kidney injury defined as a serum creatinine increase >0.3 mg/dl at 
48 hours. Using a cutoff value of 25.0 pg/ml, sensitivity, specificity and area under the receiver operating 
characteristic (ROC) curve for prediction of Acute Kidney Injury were excellent for urinary L-FABP at 12 h 
(85%, 83% and 0.95 respectively).  
There is no statistically significant differences in the levels of L-FABP between the diabetes and non-diabetes 
were noted in this study. 
Table: 2 Changes in urinary L-FABP, serum creatinine levels, eGFR and blood pressure (BP) in patients 
undergoing angiography. 






After 4 hrs After 12 
hrs 
After 24 hrs After 48 hrs 
Urinary L-FABP 
(pg/ml) 
4.3±1.42 5.75±0.78* 26.6±22.6** 38.3±26.7* 34.8±25.4 19.35±11.5 
Serum 
Creatinine, mg/dl 
1.2±0.18 ND ND ND 1.27±0.32 1.24±0.31 
eGFR by MDRD 
equation, ml/min 
80.21±21.00 ND ND ND 79.9±25.35 80.31±25.40 
Cystolic BP, 
mmHg 
138.45±30.15 129.5±32.2 ND ND 135.55±25.65 136.75±24.15 
Diastolic BP, 
mmHg 
80.5±23.1 80.6±21.0 ND ND 81.8±15.45 81.65±13.55 
 
ND: Not determined. Data given are mean values ± SD or median values (minimum-maximum) *p<0.05 vs 
baseline; **p<0.001vs baseline. 
Using the Youden index, the best cutoff value for urinary L-FABP to predict acute Kidney Injury was: 25.0pg/ml. 
 
DISCUSSION 
This clinical study of patients with normal serum creatinine who underwent angiographic procedure with 
contrast administration revealed 9% of contrast induced acute kidney injury. The diagnosis of contrast induced 
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acute kidney injury is a challenging clinical problem. Several studies have been published reporting the presence 
of elevated levels of urinary L-FABP in postcardiopulmonary bypass surgery patients
17
. Urinary L-FABP in the 
AKI patients measured 4 hours  after the surgery was significantly higher than that in the non-AKI patients, 
where as serum creatinine started to increase after 24-48 hours in the AKI patients. Receiver operating 
characteristics (ROC) curve analysis for post-CBP AKI diagnosis revealed the area under the ROC curve of 
urinary L-FABP (4 hours after surgery ) was 0.810, which is an acceptable level for the single predictive 
biomarker. Univariate logistic regression analysis showed that both bypass time and urinary L-FABP were 
significantly independent risk indicators for AKI. Liver-type fatty acid binding protein is a carrier protein having 
a molecular weight of 14 kDa and is involved in the transport of fatty acid to mitochondria or peroxisomes
11.
 
Where they are metabolized via beta-oxidation. L-FABP plays a key role in fatty acids metabolism in the 
proximal tubules of the kidney. Free fatty acids are easily transformed to non-oxidized fatty acids, and this 
transformation escalates not only with proteinuria but also with other stresses, including ischaemia and the 
presence of toxins
13. 
The most commonly used definition of CI-AKI in clinical trials is a rise in serum creatinine 
levels of 0.5 mg/dl or a 25% increase from the baseline value, assessed on day 2 after administration of contrast 
medium
18
. Recently, on the basis of the finding that even a slight elevation of serum creatinine level is associated 
with a poor outcome
19
. The Acute Kidney Injury Network (AKIN) issued a new definition for CI-AKI, which is 
a rise in serum creatinine levels of greater than 0.3 mg/dl with oliguria. This new definition may provide a new 
standard to follow
20
. The present study with the latest definition of CI-AKI, revealed 9% of CI-AKI. 
 
SUMMARY 
The present study highlighted the importance of urinary L-FABP levels in detecting Acute Kidney Injury 
associated with contrast administration earlier than Serum creatinine. Persistently increased urinary L-FABP 
levels may suggest renotubular damage in this population. Limitation of this study is that we could have missed 
patients who developed acute Kidney Injury after 48 hours of the procedure. In summary, this is the first study to 
test the efficiency of new bio-markers in this setup revealing advantages of urinary L-FABP. The population 
studied is not representative of the global group of patients with AKI associated with Contrast administration. 
Our findings may have important implications for the clinical management of patients undergoing angiographic 
procedure. Further studies in patients undergoing radio-contrast administration are required to assess the 
usefulness of L-FABP as a biomarker for early diagnosis. 
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